Răspuns terapeutic promiţător la imunoterapie într-un carcinom nazofaringian metastazat asociat cu hepatită virală C – caz clinic

Nasopharyngeal carcinoma is rare in younger people, with the highest incidence between the ages of 40 and 60 years old and, due to its particular anatomical location and lack of early symptoms, it is often diagnosed in advanced sta­ges. A thorough research of the literature reveals limited in­for­ma­tion regarding imunotherapy in cancers associated with chronic hepatitis. We report the case of a young man with me­ta­static nonkeratinizing nasopharyngeal carcinoma and viral C hepatitis, with sustained therapeutic response to standard chemotherapy and excellent outcomes with imu­no­therapy.